PTEN and carcinoma: For this purpose, we used PTEN null 786-0 carcinoma cells expressing the reverse transcriptional activator rtTA that drives a heptameric tetO sequence with minimal CMV promoter to express PTEN only in the presence of tetracycline or its analogs[28].